Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Adiponectin inhibits allograft rejection in murine cardiac transplantation.

Okamoto Y, Christen T, Shimizu K, Asano K, Kihara S, Mitchell RN, Libby P.

Transplantation. 2009 Oct 15;88(7):879-83. doi: 10.1097/TP.0b013e3181b6efbf.

2.

Effect of adiponectin on cardiac allograft vasculopathy.

Ishihara T, Haraguchi G, Konishi M, Ohigashi H, Saito K, Nakano Y, Isobe M.

Circ J. 2011;75(8):2005-12. Epub 2011 Jul 6.

3.

Loss of myeloid related protein-8/14 exacerbates cardiac allograft rejection.

Shimizu K, Libby P, Rocha VZ, Folco EJ, Shubiki R, Grabie N, Jang S, Lichtman AH, Shimizu A, Hogg N, Simon DI, Mitchell RN, Croce K.

Circulation. 2011 Dec 20;124(25):2920-32. doi: 10.1161/CIRCULATIONAHA.110.009910. Epub 2011 Dec 5.

4.

IP-10-induced recruitment of CXCR3 host T cells is required for small bowel allograft rejection.

Zhang Z, Kaptanoglu L, Tang Y, Ivancic D, Rao SM, Luster A, Barrett TA, Fryer J.

Gastroenterology. 2004 Mar;126(3):809-18.

PMID:
14988835
5.

Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection.

Morita K, Miura M, Paolone DR, Engeman TM, Kapoor A, Remick DG, Fairchild RL.

J Immunol. 2001 Sep 1;167(5):2979-84.

6.

Anti-interleukin-12/23p40 antibody attenuates chronic rejection of cardiac allografts partly via inhibition γδT cells.

Wang S, Xu X, Xie A, Li J, Ye P, Liu Z, Wu J, Rui L, Xia J.

Clin Exp Immunol. 2012 Sep;169(3):320-9. doi: 10.1111/j.1365-2249.2012.04612.x.

7.
8.

Role of CD8+ lymphocytes in chronic rejection of transplanted hearts.

Fischbein MP, Yun J, Laks H, Irie Y, Fishbein MC, Bonavida B, Ardehali A.

J Thorac Cardiovasc Surg. 2002 Apr;123(4):803-9.

10.

Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy.

Yang J, Popoola J, Khandwala S, Vadivel N, Vanguri V, Yuan X, Dada S, Guleria I, Tian C, Ansari MJ, Shin T, Yagita H, Azuma M, Sayegh MH, Chandraker A.

Circulation. 2008 Feb 5;117(5):660-9. doi: 10.1161/CIRCULATIONAHA.107.741025. Epub 2008 Jan 22.

11.

Donor T cell activation initiates small bowel allograft rejection through an IFN-gamma-inducible protein-10-dependent mechanism.

Zhang Z, Kaptanoglu L, Haddad W, Ivancic D, Alnadjim Z, Hurst S, Tishler D, Luster AD, Barrett TA, Fryer J.

J Immunol. 2002 Apr 1;168(7):3205-12.

13.

The cellular basis of cardiac allograft rejection: VIII. Mechanisms underlying delayed allograft rejection in PVG C6-deficient rats.

Merten S, Chen JC, Ha H, Plain K, Boyd RA, Penny MJ, Leenaerts P, Hall BM.

Transplantation. 1998 May 15;65(9):1152-8.

PMID:
9603160
14.
16.

CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.

Hüser N, Tertilt C, Gerauer K, Maier S, Traeger T, Assfalg V, Reiter R, Heidecke CD, Pfeffer K.

Eur J Immunol. 2005 Jan;35(1):128-38.

17.

Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.

Yun JJ, Whiting D, Fischbein MP, Banerji A, Irie Y, Stein D, Fishbein MC, Proudfoot AE, Laks H, Berliner JA, Ardehali A.

Circulation. 2004 Feb 24;109(7):932-7. Epub 2004 Feb 2.

18.

Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice.

Wasowska BA, Qian Z, Cangello DL, Behrens E, Van Tran K, Layton J, Sanfilippo F, Baldwin WM 3rd.

Transplantation. 2001 Mar 27;71(6):727-36.

PMID:
11330533
19.

Donor IFN-gamma receptors are critical for acute CD4(+) T cell-mediated cardiac allograft rejection.

Wiseman AC, Pietra BA, Kelly BP, Rayat GR, Rizeq M, Gill RG.

J Immunol. 2001 Nov 1;167(9):5457-63.

Supplemental Content

Support Center